Becker's Hospital Review

FDA scolds drugmaker for 'false or misleading' claims

The FDA has reprimanded Dexcel and its affiliate Edenbridge Pharmaceuticals for "false or misleading" promotional claims regarding its brand-name drug Hemady. 

Mar 6, 2025 - 00:22
 0
FDA scolds drugmaker for 'false or misleading' claims

The FDA has reprimanded Dexcel and its affiliate Edenbridge Pharmaceuticals for "false or misleading" promotional claims regarding its brand-name drug Hemady. 

Read More

Tags:

Previous Article

U.S. judge blocks NIH’s plan to slash overhead cost payments

Next Article

SLS Barcelona To Open Its Doors This April

Related Posts

How a former Mayo Clinic leader is building AdventHealth's hospital at home

How a former Mayo Clinic leader is building AdventHealt...

Feb 13, 2025  0

Healthcare execs confront safety as a purpose

Healthcare execs confront safety as a purpose

Feb 18, 2025  0

Trump's policies could curb nurse visas, worsen shortages

Trump's policies could curb nurse visas, worsen sh...

Feb 12, 2025  0